Aparicio T, Kermorgant S, Dessirier V, Lewin MJ and Lehy T (1999) Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis20: 1445–1451 ArticleCASPubMed Google Scholar
Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ and Ellis LM (2000a) Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer89: 488–499 ArticleCASPubMed Google Scholar
Bruns CJ, Solorzano CC, Harbison MT, Ozawa S, Tsan R, Fan D, Abbruzzese J, Traxler P, Buchdunger E, Radinsky R and Fidler IJ (2000b) Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res60: 2926–2935 CASPubMed Google Scholar
Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR and Tortora G (1999) Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res5: 909–916 CASPubMed Google Scholar
Copeland EM, Miller LD and Jones RS (1968) Prognostic factors in carcinoma of the colon and rectum. Am J Surg116: 875–881 ArticleCASPubMed Google Scholar
Folkman J (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis [see comments]. N Engl J Med333: 1757–1763 ArticleCASPubMed Google Scholar
Goldstein NI, Prewett M, Zuklys K, Rockwell P and Mendelsohn J (1995) Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res1: 1311–1318 CASPubMed Google Scholar
Ke L, Qu H, Nagy JA, Eckelhoefer IA, Masse EM, Dvorak AM and Dvorak HF (1996) Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor. Eur J Cancer32A: 2467–2473 Google Scholar
Liu B, Fang M, Schmidt M, Lu Y, Mendelsohn J and Fan Z (2000) Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer82: 1991–1999 ArticleCASPubMedPubMed Central Google Scholar
Marcus EA, Weber TK, Rodriguez-Bigas MA, Driscoll D, Meropol NJ and Petrelli NJ (1999) Prognostic factors affecting survival in patients with colorectal carcinomatosis. Cancer Invest17: 249–252 ArticleCASPubMed Google Scholar
Morikawa K, Walker SM, Jessup JM and Fidler IJ (1988) In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res48: 1943–1948 CASPubMed Google Scholar
Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R and Dinney CP (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res5: 257–265 CASPubMed Google Scholar
Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P and Hicklin DJ (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res59: 5209–5218 CASPubMed Google Scholar
Radinsky R Risin, Fan, Dong, Bielenberg, Bucana, Fidler (1995) Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res1: 19–31 CASPubMed Google Scholar
Senger DR, Connolly DT, Van de Water L, Feder J and Dvorak HF (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res50: 1774–1778 CASPubMed Google Scholar
Shaheen RM, Davis DW, Liu W, Zebrowski BK, Wilson MR, Bucana CD, McConkey DJ, McMahon G and Ellis LM (1999) Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res59: 5412–5416 CASPubMed Google Scholar
Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res55: 3964–3968 CASPubMed Google Scholar
United Kingdom Co-ordinating Committee on Cancer Research (U.K. C. C. C. R) (1998) Guidelines for the welfare of animals in experimental neoplasia. Br J cancer77: 1–10
Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P and Bohlen P (1998) Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer Metastasis Rev17: 155–161 ArticleCASPubMed Google Scholar
Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr and Ellis LM (1999) Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res5: 3364–3368 CASPubMed Google Scholar